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The prevalence of nonimmunological hydrops fetalis has been reported between 1 in 
1500 and 1 in 4000, with an approximate 80% mortality rate. This case-report study 
explains a case of hydrops fetalis, presented with generalized edema and pleural and 
pericardial effusion at 30 weeks of gestation with preterm birth at this age due to 
preterm uterine contractions. No etiology was found for hydrops and all signs 
resolved thoroughly after birth without treatment. After birth, the newborn was 
admitted to neonatal intensive care unit and discharged after 47 days in good 
condition. The infant was completely healthy within three months after delivery. 
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Hydrops fetalis means the abnormal collection of 
fluid in fetal soft tissues and serous cavities. 
Nonimmune hydrops fetalis (NIHF) includes cases not 
affected by red cell alloimmunization. The incidence of 
NIHF is 1:1500 to 1:4000. At the moment, NIHF 
includes about 90% of hydrops fetalis cases (1-2). 
The prenatal diagnosis of hydrops fetalis is based on 
ultrasound examination findings, including two or 
more of the following: ascites, pleural effusion, 
pericardial effusion, Skin edema (>5 mm). The 
etiology is determined in 60% to 85% of cases, 
prenatally or postnatally (3). The etiology of hydrops 
cases is related to the gestational age of presentation. 
NIHF before 24 weeks of gestation is usually related to 
an aneuploidy, whereas cardiac and pulmonary 
anomalies, and infectious disease cause most cases 
after 24 weeks of gestation (4). Cardiovascular 
abnormalities are reported in 40% of cases of NIHF (5). 
Aneuploidy is responsible for seven to 16% of NIHF 
cases. The most common aneuploidy associated with 
NIHF is monosomy X (5). Severe fetal anemia due to 
high output cardiac failure (6) accounts for 10% to 27% 
of cases (5). Infections are responsible for five to 10% 
percent of NIHF cases (7). Parvovirus B19 is the most 
common infection in hydropic fetuses. Thoracic 
anomalies account for 10% of the cases. Primary 
congenital pulmonary lymphangiectasis results from 
thoracic duct obstruction, while secondary congenital 
pulmonary lymphangiectasis results from thoracic 
masses or congenital heart disease (8-9). 
Fetal/placental vascular tumors due to arteriovenous 
shunting and high cardiac output failure can lead to 
hydrops. Metabolic disorders include a group of 
autosomal recessive diseases present in the fetal period 
as NIHF (7). Skeletal dysplasias may be the cause of 
nonimmune hydrops fetalis (7).  
NIHF is associated with a perinatal mortality rate of 
50% to 98% (10-12). Prognosis depends on the 
etiology, the gestational age at the onset of hydrops, the 
gestational age at delivery, and the presence of pleural 
effusions. Generally, the early hydrops is associated 
with poorer outcome. Pleural effusions and 
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polyhydramnios before 20 weeks of gestation due to 
increased risks of pulmonary hypoplasia and preterm 
delivery are poor prognostic factors. The absence of 
aneuploidy and major structural anomalies have a 
better outcome (13). 
The present report explains a case of hydrops fetalis 




A 31 years old gravid2 woman with a previous 
cesarean delivery was referred to Yas hospital at 30 
weeks of gestation. The chief complaint was labor pain, 
and the patient had an ultrasound report of 
polyhydramnios (AF=38) that had been performed 
about two weeks ago. Our center's ultrasonographic 
examination showed severe hydrops fetalis with 
generalized edema, bilateral hydrothorax and collapsed 
lungs, and pericardial effusion (see Figures 1-7). The 
amniotic fluid index was 45cm; neither anemia nor 
fetal anomaly was detected. Biometric parameters were 
appropriate for the gestational week. A detailed 
ultrasound examination for anomalies of the fetus, 
placenta, and the umbilical cord was done before 
delivery by a maternal-fetal specialist, and no abnormal 
finding was found. An overview of maternal docu-
ments and the first and second-trimester aneuploidy 
screening was indicative of low risk. Nucal thickness 
in the first trimester was in the normal range; detailed 
ultrasound examination for anomaly scanning at 20 
weeks of gestation was normal. Due to the rapid 
progression of labor to the active phase, the cesarean 
section was done in the presence of a neonatologist, 
and a female infant weighing 1800 g, with Apgar 3 and 
normal ABG, was delivered. Intubation was done, and 
the newborn was admitted to neonatal intensive care 
unit (NICU). Further evaluation to detect the cause of 
hydrops fetalis was done after delivery.  
After birth, in neonatal evaluation, a detailed 
examination of the newborn was done by a 
neonatologist, and there was no abnormal finding. 
Polymerase chain reaction (PCR) test for toxoplasma, 
rubella, parvovirus B19 of blood specimens, and PCR 
test for cytomegalovirus (CMV) on urine specimen 
were negative. As congenital cardiac diseases are one 
of the most well-known causes of NIHF, we performed 
neonatal echocardiography after birth, and it was 
normal (we did not have enough time to do it before 
delivery). Fetal heart rate (FHR) pattern before birth 
was regular. The middle cerebral artery Doppler 
studies to assess fetal anemia and newborn hemoglobin 
were in the normal range (14.9); therefore, anemia was 
not considered.  
The umbilical cord and placenta appeared normal 
and histopathologic examination by a pathologist 
showed no abnormality. 
In maternal evaluation, complete blood cell count 
and indices were normal. The maternal blood group 
was A+, the antibody screen was negative, serologic 
test for syphilis, and antibodies for toxoplasma, CMV, 
rubella, and parvovirus B19 were negative.  
Genetic abnormalities as a cause of NIHF must be 
excluded. Familial history to rule out an inherited 
disorder in the family is essential. In our case, family 
history was negative, and karyotype evaluation after 
birth showed a normal female chromosomal 
complement, and no further evaluation was done. The 
analysis of thoracentesis fluid was normal with 
negative culture. In the end, we did not find any 
abnormal findings.  
 
 
Figure 1. Bilateral pleural effusion in Transverse view 
of the fetal thorax 
 
 
Figure 2. Coronal view of the face with normal lip and 
mouth 
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Figure 3. Maximal vertical pocket 
 
 








Figure 6. Fetal skull with skin edema 
 
Figure 7. The middle cerebral artery Doppler 
 
The newborn was admitted to NICU and 
thoracentesis was done (20 cc). Ventilatory support and 
surfactant replacement were carried out to treat 
respiratory distress syndrome (RDS), similar to other 
premature infants. The infant was discharged after 48 
days in good condition. The child was entirely healthy, 
physical and neurodevelopmental status was normal till 
6 months after delivery. 
 
Discussion 
Sonographic diagnosis of hydrops fetalis is simple. 
The issue is to determine the etiology, the proper 
therapy, timing of delivery, and evaluation of prognostic 
factors. 
Few cases of idiopathic hydrops fetalis with total 
resolution have been reported in the literature. Iskaros 
reported 45 cases of nonimmunological fetal hydrops 
between 11 and 17 weeks of gestation during four years. 
Four of these cases were considered as idiopathic cases, 
and in all of them, the hydrops resolved before 24 weeks 
of gestation (14).  
Ramon et al. examined prognostic factors in NIHF. 
Ultrasonographic evidence of malformation and/or the 
presence of persistent pleural effusions were two factors 
associated with poor perinatal outcome. When pleural 
effusions were demonstrated by ultrasound and lung, the 
thoracic ratio was less than 0.6, severe lung hypoplasia 
was documented by histopathologic examination, and 
the perinatal mortality rate was 100% (15). Therefore the 
absence of these two factors is associated with a better 
outcome, which is in accordance with our case. 
A retrospective cohort study was conducted by Nassr 
et al., including 142 cases of NIHF. They evaluated the 
effect of etiology, location of fluid collection, and 
gestational age at delivery on survival. According to 
underlying etiology, nonimmune hydrops was 
associated with a 37% risk of neonatal mortality and a 
50% chance of survival. Ascites independently predicted 
perinatal mortality (16). In our case, we did not find 
ascites that can be compatible with a good prognosis 
before and after birth.   
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KIM, Lee et al. conducted a numeric score called the 
ultrasonographic severity scoring of non-immune 
hydrops (USNIH). Perinatal mortality rate was higher in 
patients with USNIH≥3 points compared to those who 
scored 2 points. They found this system may be reliable 
to predict perinatal outcomes in nonimmune hydrops, 
especially in idiopathic cases (17). According to this 
article, there are some criteria to predict the prognosis of 
NIHF that can guide us in managing these cases. 
Swain et al. surveyed the prevalence, etiology, and 
outcome of 40 cases of nonimmunological hydrops 
fetalis. Only two of the 14 idiopathic cases survived. The 
first one was diagnosed at 31 weeks of gestation, and the 
second case at 30 weeks of gestation (18). This shows 
the importance of the gestational age at which hydrops 
fetalis is diagnosed. Like the two cases mentioned in this 
study, our case has a late onset of hydrops fetalis. 
In the present case-report, we described a fetus with 
nonimmunologic hydrops fetalis, which had unknown 
etiology, and resolved entirely with no intervention after 
preterm birth. We conclude that even severe 
nonimmunologic hydrops fetalis can resolve 
completely, especially if there are no associated 
congenital malformations, chromosomal disorders, 
intrauterine infections, or tumors, and particularly when 
it is diagnosed late in pregnancy, similar to our case. Due 
to the probability of spontaneous resolution and good 
outcome in these rare cases with an idiopathic etiology, 
conservative expectant management should be the first 
treatment choice. 
In our case, we did not expect a good prognosis 
according to ultrasound findings that were compatible 
with severe hydrops fetalis. Pleural effusion was 
massive, and the lungs appeared hypoplastic. A 
straightforward attitude to this case, considering no signs 
of associated congenital malformations, late onset of the 
disorder, and negative familial history, could favor a 
good prognosis. These early findings could give us a 
choice to select a more conservative approach, including 
inhibition of uterine contraction with tocolysis, 
amnioreduction for maternal comfort and resolving 
uterine distention, and maybe intra uterine interventions 
like the placement of a thoracic shunt. Xia et al. 
examined twelve cases with severe fetal primary 
hydrothorax, who underwent prenatal intervention. They 
concluded antenatal intervention might enhance the 




According to this case report and other mentioned 
studies, severe NIHF is not necessarily associated with 
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